In addition to an injection given under your skin, Imitrex is also available as an oral tablet and a nasal spray. Imitrex belongs to a group of drugs called triptans. This article describes the ...

Sumatriptan 5mg, 20mg; per spray. The vascular 5-HT 1 receptor subtype to which sumatriptan binds selectively, and through which it presumably exerts its antimigrainous effect, is present on cranial ...

Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal ...

Lannett announced that the FDA has approved Sumatriptan Nasal Spray, the generic version of GlaxoSmithKline's Imitrex Nasal Spray. Lannett announced that the Food and Drug Administration (FDA) has ...

Use Imitrex exactly as it was prescribed for you. Do not use the medication in larger or smaller amounts, or use it for longer than recommended by your doctor. Take one Imitrex tablet whole with a ...

MAPLE GROVE, Minn., Oct. 2, 2019 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Tosymra ™ (sumatriptan) Nasal Spray, 10 mg for the acute treatment of ...

The FDA has approved sumatriptan nasal spray (Tosymra) for the acute treatment of migraine with or without aura in adults. The FDA has approved sumatriptan nasal spray (Tosymra) for the acute ...

Sumatriptan is one of the most commonly prescribed medications to treat migraine attacks. As the pioneer in the triptan class ...

Your doctor may recommend Imitrex to treat migraine that occurs with or without an aura. Imitrex injections may also be used to treat cluster headaches. There are some limitations of use for Imitrex.

Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...

Imitrex (sumatriptan) is a brand-name drug that’s prescribed for migraine and cluster headaches in adults. As with other drugs, Imitrex can cause side effects, such as dizzy spells. Imitrex is ...

MUMBAI, India, March 2, 2021 /CNW/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug ...